Aryeh Jason, a director, made one open market purchase of Orchestra BioMed Holdings, Inc. ($OBIO) shares worth $2,450 in the last 365 days, with the most recent on September 19, 2025. This ranks 4,727th among 4,983 insiders, below the average of $1.5 million per buyer across 3.29 transactions. He also sold LIGAND PHARMACEUTICALS INC ($LGND) shares on the open market three times for a total of $1.7 million, most recently on September 23, 2025. This places 3,800th out of 11,678 insiders, under the average of $8.6 million across 6.37 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 8, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | M | Non-Qualified Stock Option (right to buy) | 2034 | $0.00 | 0.0000 | 20,629,000 | 100.00% | 0.01% |
| Dec. 8, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | M | Common Stock | 2034 | $69.51 | 127,942.0000 | 20,629,000 | 1.62% | 0.01% |
| Sept. 23, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | S | Common Stock | 4418 | $170.41 | 131,490.0000 | 18,290,000 | 3.25% | 0.02% |
| Sept. 23, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | S | Common Stock | 954 | $171.92 | 125,908.0000 | 18,290,000 | 0.75% | 0.01% |
| Sept. 23, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | S | Common Stock | 4628 | $170.96 | 126,862.0000 | 18,290,000 | 3.52% | 0.03% |
| Sept. 19, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | P | Common Stock, par value $0.0001 per share | 1000 | $2.45 | 108,482.0000 | 38,392,716 | 0.93% | 0.00% |
| Aug. 7, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 15000 | $0.00 | 107,482.0000 | 38,392,716 | 16.22% | 0.04% |
| July 15, 2025 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Aryeh Jason | Director | A | Common Stock | 19506 | $0.00 | 44,060.0000 | 0 | 79.44% | 0.00% |
| June 24, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Stock Option (Right to Buy) | 36797 | $0.00 | 36,797.0000 | 38,235,409 | 9999.99% | 0.10% |
| June 24, 2025 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 12422 | $0.00 | 92,482.0000 | 38,235,409 | 15.52% | 0.03% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | A | Non-Qualified Stock Option (right to buy) | 5783 | $0.00 | 5,783.0000 | 18,290,000 | 9999.99% | 0.03% |
| June 6, 2025 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | A | Common Stock | 1209 | $0.00 | 135,908.0000 | 18,290,000 | 0.90% | 0.01% |
| April 4, 2025 | Anebulo Pharmaceuticals, Inc. | $ANEB | Aryeh Jason | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2025 | Anebulo Pharmaceuticals, Inc. | $ANEB | Aryeh Jason | Director | A | Stock Option (right to buy) | 4964 | $0.00 | 4,964.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | M | Common Stock, par value $0.0001 per share ("Common Stock") | 11700 | $4.30 | 80,060.0000 | 37,621,495 | 17.12% | 0.03% |
| Dec. 27, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | M | Stock Option (Right to Buy) | 11700 | $0.00 | 6,900.0000 | 37,621,495 | 62.90% | 0.03% |
| Aug. 19, 2024 | LIFECORE BIOMEDICAL, INC. DE | $LFCR | Aryeh Jason | Director | A | Common Stock | 24554 | $0.00 | 24,554.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Stock Option (Right to Buy) | 17068 | $0.00 | 17,068.0000 | 35,777,877 | 9999.99% | 0.05% |
| June 20, 2024 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 5376 | $0.00 | 68,360.0000 | 35,777,877 | 8.54% | 0.02% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | A | Common Stock | 1252 | $0.00 | 134,699.0000 | 17,757,000 | 0.94% | 0.01% |
| June 14, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | A | Non-Qualified Stock Option (right to buy) | 5444 | $0.00 | 5,444.0000 | 17,757,000 | 9999.99% | 0.03% |
| June 13, 2024 | Anebulo Pharmaceuticals, Inc. | $ANEB | Aryeh Jason | Director | A | Stock Option (right to buy) | 41667 | $0.00 | 41,667.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Anebulo Pharmaceuticals, Inc. | $ANEB | Aryeh Jason | Director | A | Stock Option (right to buy) | 2482 | $0.00 | 2,482.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | M | Non-Qualified Stock Option (right to buy) | 2406 | $0.00 | 0.0000 | 17,757,000 | 100.00% | 0.01% |
| April 30, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | M | Common Stock | 2406 | $52.30 | 133,447.0000 | 17,757,000 | 1.84% | 0.01% |
| March 5, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | M | Non-Qualified Stock Option (right to buy) | 2893 | $0.00 | 0.0000 | 17,757,000 | 100.00% | 0.02% |
| March 5, 2024 | LIGAND PHARMACEUTICALS INC | $LGND | Aryeh Jason | Director | M | Common Stock | 2893 | $39.35 | 131,041.0000 | 17,757,000 | 2.26% | 0.02% |
| July 20, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 34,613,466 | 9999.99% | 0.07% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Nonstatutory Stock Option (Right to Buy) | 23250 | $0.00 | 23,250.0000 | 14,988,584 | 9999.99% | 0.16% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Right to Receive Earnout Shares | 22492 | $0.00 | 22,492.0000 | 14,988,584 | 9999.99% | 0.15% |
| April 12, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | M | Right to Receive Earnout Shares | 11246 | $0.00 | 11,246.0000 | 27,643,549 | 9999.99% | 0.04% |
| April 12, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | M | Common Stock, par value $0.0001 per share ("Common Stock") | 11246 | $0.00 | 62,984.0000 | 27,643,549 | 21.74% | 0.04% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Nonstatutory Stock Option (Right to Buy) | 6975 | $0.00 | 6,975.0000 | 14,988,584 | 9999.99% | 0.05% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Nonstatutory Stock Option (Right to Buy) | 23250 | $0.00 | 23,250.0000 | 14,988,584 | 9999.99% | 0.16% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Common Stock, par value $0.0001 per share ("Common Stock") | 51738 | $0.00 | 51,738.0000 | 14,988,584 | 9999.99% | 0.35% |
| Jan. 26, 2023 | Orchestra BioMed Holdings, Inc. | $OBIO | Aryeh Jason | Director | A | Nonstatutory Stock Option (Right to Buy) | 18600 | $0.00 | 18,600.0000 | 14,988,584 | 9999.99% | 0.12% |